Retinoblastoma (reh-tin-oh-blast-oma) is a childhood cancer
arising from immature retinal cells in one or both eyes and can strike from the
time a child is in the womb up to 5 years of age. This cancer is curable if
caught early enough. However, 87% of the children stricken with this disease
worldwide die, mostly in developing countries. In developed countries, 97% of
those who do live have moderate to severe visual impairment or the child may
loose one or both eyes.
Retinoblastoma is a relatively uncommon tumor of childhood that
accounts for about 3% of the cancers in children under the age of 15. The
tumors originate in the retina, the light sensitive layer of the eye, which
enables the eye to see. When the tumors are present in one eye, it is referred
to as unilateral retinoblastoma, and when it occurs in both eyes it is referred
to as bilateral retinoblastoma. 60% of the cases involve only one eye
(unilateral); the rest affect both eyes (bilateral). 90% of retinoblastoma
patients have no family history of the disease and only 10% of newly diagnosed
patients have other family members with retinoblastoma.
Early diagnosis and intervention is
critical to the successful treatment of this disease.
Common signs of retinoblastoma include:
- A white
"glow" or "glint" in the pupil of one or both eyes in dim
lighting
- White pupil in a color photo
- Crossed or misaligned eyes
New Brochure Promoting Early
Detection
Although it is rare, retinoblastoma can spread or metastasize
outside of the eye to the brain, the central nervous system (brain and spinal
cord), and the bones. In these cases, chemotherapy is prescribed by a
pediatric oncologist and is administered through the peripheral blood vessels
or into the brain for months to years after initial diagnosis of metastatic
disease.
Kuldeep Raizada completed his basic optometry education at Gandhi Eye Hospital, Aligarh, and has his training at L V Prasad Eye Institute, Hyderabad. where he was also Founder and Head of the Department of Ocular Prosthesis services till 2009. He completed a second fellowship, in Anaplastolgy, at MD Anderson Cancer Centre, Houston. He has also been trained by the top most ocularist and anaplastologist in United States of America.
His clinical interests include ocular and facial prosthesis, particularly in pediatric patients. His research interests lie in newer advancement in development of new types of prosthesis, newer solution for ptosis corrective glasses.
Kuldeep Raizada, is Founder & Director of the International Prosthetic Eye Center since 2010, where he is practicing since 2010.
Kuldeep Raizada has been recognized by the American Society of Ocularist, USA and American Anaplastology Association,USA and by several other professional organizations, for his excellence in research and clinical practice.
Kuldeep Raizada, have completed all requirements by American Society of Ocularist, which is hard work of 14000 working hours as well extensive study for prosthetics, Hence awarded the Diplomate Ocularist from American Society of Ocularist, USA, 2012, Chicago, USA, which is the First ever received all over Asia Pacific & throughout Middle East so ever.
At present he is reviewer of several journals like Contact Lens & Anterior Eye, International Journal of Anaplastology, Oculoplasty & Reconstructive Surgery (OPRS) and Many others. He has published and presented world widely
